Oromandibular dystonia

Signs and symptoms

Clinical manifestations vary depending on the muscles involved, the extent of OMD, and its distribution. Impaired mastication, dysphagia, dysphonia (alteration of speech), mandibular disorders (TMD) such as open locks, unconscious mandibular opening and closing, and pulling and twisting of the mandible forward or laterally are examples of dysfunctions.

Indications of dystonic spasms include platysma spasms, mouth corner retractions, tongue dyskinesia, bruxism, lip pursing or sucking, facial grimacing, and nasal contractions. Breathing issues or dysarthria are also infrequently reported.

The onset of symptoms is more common in women and typically occurs between the ages of 40 and 70. The symptoms only show up when speaking or masticating, for example. Typically, patients list stress, talking, chewing, praying, and chewing objects as triggers. Routine lab tests are typically normal. Most of the time, it is reported that poor oral function is linked to social embarrassment, a lower quality of life, depression, and weight loss.

Causes

OMD can be acquired, inherited, or idiopathic. The clinical presentation of a more complicated degenerative movement disorder may include inherited OMD. Patients with inherited focal OMD have also been documented to have dystonia type 6, dystonia type 4, and dystonia type 16. Medication-induced OMD is the most prevalent type of acquired OMD. Although there have been several reports of OMD cases following dental work, it is still unknown whether these procedures are linked to the onset of dystonic symptoms. Similarly, it is unknown how much peripheral trauma contributes to OMD risk.

Diagnosis

Because OMD can manifest in a variety of ways and to varying degrees, diagnosing it is a clinical and challenging process. Since there is no medical test that can diagnose it, the diagnosis is made based on the patient's medical history, physical examination, neurological examination, and intramuscular electromyography (EMG) confirmation.

Hemifacial spasm, psychological disorders, and TMJ disorders (such as bruxism or spontaneous condylar dislocation) are included in the differential diagnosis.

Treatment

The effectiveness of the different medications currently used to treat dystonia is not well-documented. Nonetheless, lithium, levodopa, dopamine receptor antagonists, carbamazepine, anticonvulsants, antiparkinson drugs, benzodiazepines, baclofen, and anticholinergic are a few of the medications used to treat OMD.

It is believed that over time, physiotherapy will encourage brain rewiring, which will lessen dystonic movements. This response is widely recognized among musicians.

Injections of botulinum neurotoxins (BoNT), a potent neurotoxin that inhibits acetylcholine release at the presynaptic junction and causes transient chemical denervation of skeletal muscles, are a promising treatment for OMD.

Epidemiology

OMD is thought to affect 68.9 cases per million people. OMD typically manifests itself during the sixth decade of life. Almost twice as many women as men are impacted.

References

References

1. "Etiology, Diagnosis and Management of Oromandibular Dystonia: an Update for Stomatologists". Shiraz University of Medical Sciences.
2. Jankovic, Joseph. (2003). "Office Practice of Neurology". Elsevier.
3. (2017). "Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment". Elsevier BV.
4. (2013-12-02). "The role of a dentist in managing patients with dystonia". Dental Update.
5. (2015). "Oromandibular dystonia". Elsevier BV.
6. (2013). "Oromandibular dystonia—functional and clinical characteristics: a report on 21 cases". Elsevier BV.
7. Chidiac, José Johann. (March 2, 2011). "Oromandibular dystonia treatment following a loss of vertical dimension". Mark Allen Group.
8. (2011). "Oromandibular dystonia: A clinical report". Elsevier BV.
9. (April 30, 2014). "Clinical, Etiological, and Therapeutic Features of Jaw-opening and Jaw-closing Oromandibular Dystonias: A Decade of Experience at a Single Treatment". Ubiquity Press, Ltd..
10. (2022). "Pathophysiological mechanisms of oromandibular dystonia". Elsevier BV.
11. (August 17, 2011). "Identification and functional analysis of novel THAP1 mutations". Springer Science and Business Media LLC.
12. (March 29, 2021). "Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update". Frontiers Media SA.
13. (2016). "Understanding dystonia: diagnostic issues and how to overcome them". FapUNIFESP (SciELO).
14. (June 1, 1986). "Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm.". BMJ.
15. (December 1, 1988). "Dystonia and tremor induced by peripheral trauma: predisposing factors.". BMJ.
16. (2020). "Does acute peripheral trauma contribute to idiopathic adult-onset dystonia?". Elsevier BV.
17. (June 24, 2014). "An evaluation of the role of environmental factors in the disease penetrance of cervical dystonia". BMJ.
18. (November 1, 1998). "Peripherally induced oromandibular dystonia". BMJ.
19. "Etiology, Diagnosis and Management of Oromandibular Dystonia: an Update for Stomatologists". Shiraz University of Medical Sciences.
20. (2012). "Oromandibular dystonia after dental treatments: a report of two cases". The Korean Association of Oral and Maxillofacial Surgeons.
21. (2015). "Recent developments in dystonia". Ovid Technologies (Wolters Kluwer Health).
22. (2015). "Diagnosis and Treatment of Dystonia". Elsevier BV.
23. (March 2009). "Oromandibular dystonia following dental treatment: case reports and discussion". The New Zealand Dental Journal.
24. (1988). "Epidemiology of focal and generalized dystonia in Rochester, Minnesota". Wiley.
25. (May 25, 2018). "Oromandibular Dystonia: Demographics and Clinical Data from 240 Patients". The Korean Movement Disorder Society.
26. (1999). "Sex-related influences on the frequency and age of onset of primary dystonia". Ovid Technologies (Wolters Kluwer Health).